FAM21C inhibitors comprise a specific category of chemical compounds designed to reduce the functional activity of the FAM21C protein. The FAM21C protein is integral to the endosomal sorting complexes required for transport (ESCRT) pathway, which is critical for trafficking membrane proteins for degradation or recycling. FAM21C, as a part of the WASH complex, is responsible for actin polymerization that promotes endosomal protein sorting. Inhibitors targeting this protein disrupt the actin polymerization process, thereby impeding the FAM21C-mediated sorting of endosomal cargoes. This disruption can lead to a cascade of effects within cellular trafficking, potentially affecting cellular functions reliant on proper sorting and recycling of membrane proteins. The chemical inhibitors specifically bind to domains of the FAM21C protein, altering its conformation and preventing its interaction with other components of the WASH complex. This precise binding means that the inhibitors selectively affect the FAM21C protein's function without necessarily interfering with the broader ESCRT machinery. The specificity of these inhibitors makes them particularly valuable for investigating the cellular processes that FAM21C is involved in and understanding the protein's role in the intricate network of intracellular trafficking.
Beyond their use in research, FAM21C inhibitors serve as a tool for dissecting the molecular mechanisms governing endosomal sorting and actin dynamics. The functional inhibition is achieved through a variety of mechanisms, such as competitive binding to the actin-related protein 2/3 (Arp2/3) complex-binding site on FAM21C, preventing the initiation of actin nucleation. Other inhibitors may impede the interaction between FAM21C and VPS35, a component of the retromer complex, crucial for retrograde transport from endosomes to the trans-Golgi network. By blocking these specific interactions, FAM21C inhibitors effectively diminish the protein's ability to coordinate the spatial and temporal aspects of actin assembly on endosomes. This leads to a reduction in membrane bending and fission events that are necessary for the proper sorting of endosomal contents. The study of these inhibitors sheds light on the fundamental operations of cellular trafficking and the maintenance of cellular homeostasis, providing insights into the underpinnings of cellular organization and the maintenance of intracellular pathways.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $151.00 $609.00 | 75 | |
NSC 23766 inhibits the interaction between Rac1 and its GEFs, interfering with Rac1 activation. As Rac1 is involved in actin polymerization, this indirectly affects FAM21C by modifying the actin cytoskeleton remodeling it regulates. | ||||||
Src kinase inhibitor I | 179248-59-0 | sc-204303 sc-204303A | 1 mg 10 mg | $53.00 $204.00 | 11 | |
Src inhibitor-1 blocks Src family kinase activity, which is involved in various signaling pathways including actin cytoskeleton dynamics. This inhibits FAM21C function indirectly by altering the cytoskeletal architecture it depends on. | ||||||